QSITA-M 50/1000MG SITAGLIPTIN 50MG+METFORMIN 1000MG TABS 10’S

Quita-M is a combination medication that contains Sitagliptin 50mg and Metformin 1000mg. It is primarily used in the management of type 2 diabetes mellitus. Sitagliptin is a DPP-4 inhibitor that helps to increase insulin production and decrease glucose production in the liver, while Metformin is a biguanide that improves insulin sensitivity and reduces glucose absorption in the intestines.

Together, these components work synergistically to help control blood sugar levels in adults with type 2 diabetes, especially when diet and exercise alone are insufficient. Quita-M is often prescribed for patients who need better glycemic control and is beneficial in reducing the risk of diabetes-related complications. It is important for patients to follow their healthcare provider’s instructions regarding dosage and lifestyle modifications to achieve optimal results. In Kenya, Quita-M is a valuable option for diabetes management, contributing to improved health outcomes for patients.